M445-0143 Screening compound: N-[(3-ethoxyphenyl)methyl]-3-[4-oxo-2-(pyrrolidin-1-yl)-3H,4H-thieno[3,2-d]pyrimidin-3-yl]propanamide

M445-0143 Screening compound: N-[(3-ethoxyphenyl)methyl]-3-[4-oxo-2-(pyrrolidin-1-yl)-3H,4H-thieno[3,2-d]pyrimidin-3-yl]propanamide
M445-0143 Screening compound: N-[(3-ethoxyphenyl)methyl]-3-[4-oxo-2-(pyrrolidin-1-yl)-3H,4H-thieno[3,2-d]pyrimidin-3-yl]propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound M445-0143
N-[(3-ethoxyphenyl)methyl]-3-[4-oxo-2-(pyrrolidin-1-yl)-3H,4H-thieno[3,2-d]pyrimidin-3-yl]propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M445-0143

Molecular Formula

C22H26N4O3S (C22 H26 N4 O3 S)

Compound Name

N-[(3-ethoxyphenyl)methyl]-3-[4-oxo-2-(pyrrolidin-1-yl)-3H,4H-thieno[3,2-d]pyrimidin-3-yl]propanamide

IUPAC name

N-[(3-ethoxyphenyl)methyl]-3-[4-oxo-2-(pyrrolidin-1-yl)-3H4H-thieno[32-d]pyrimidin-3-yl]propanamide

SMILES

CCOc1cccc(CNC(CCN(C2=O)C(N3CCCC3)=Nc3c2scc3)=O)c1

InChI

InChI=1S/C22H26N4O3S/c1-2-29-17-7-5-6-16(14-17)15-23-19(27)8-12-26-21(28)20-18(9-13-30-20)24-22(26)25-10-3-4-11-25/h5-7,9,13-14H,2-4,8,10-12,15H2,1H3,(H,23,27)

InChI Key

VSHOTQRGPNDHPW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27541675

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

426.54

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.118

Distribution Coefficient, logD

3.118

Water Solubility, LogSw

-3.47

Polar Surface Area

61.780

Acid Dissociation Constant (pKa)

13.17

Base Dissociation Constant (pKb)

-0.25

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.90

M445-0143 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
Structure:
  • Mimetics
Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
  • Proteases

References: we are preparing a list of scientific research reports with M445-0143 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound M445-0143?
Check Price and Availability of M445-0143, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of M445-0143 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for M445-0143
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for M445-0143
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of M445-0143 available by request